Mallinckrodt Plc Overview
Get informed when a big investor buys or sells
+ Follow-45.43%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Mallinckrodt Plc (MNKKQ) currently reports a ROE of -45.43%. That is above the Healthcare sector average of -75.84%. Use the charts on this page to explore Mallinckrodt Plc's ROE history and peer comparisons.
Mallinckrodt Plc's ROE of -45.43% is higher than the Healthcare sector average of -75.84%. That is roughly 40.1% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Mallinckrodt Plc's current -45.43% should be judged against Healthcare norms (sector average: -75.84%) and against MNKKQ's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -45.43%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -75.84%. From there, open related valuation or income-statement pages for Mallinckrodt Plc, and consider following MNKKQ for alerts when major investors trade the stock.
Mallinckrodt Plc is classified in the Healthcare sector. On ROE, it currently shows -45.43% versus a sector average near -75.84%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MNKKQ with unrelated industries.
